Professor Dr. Per Borghammer explains the brain-first vs body-first model of Parkinson’s disease, which consists of two distinct pathways of disease progression starting from the gut, or nose. Learn how these findings could potentially pave the way for personalized medicine and new treatments to stop Parkinson’s disease in its tracks.
Learn how these findings could potentially pave the way for personalized medicine and new treatments to stop Parkinson’s disease in its tracks.
Related content
A table that provides you an overview on non-motor symptoms common in Parkinson’s disease
In this slide deck, cognitive disorders, mood disorders, quality of life and the comorbidities of PD are discussed
This image includes an analysis of 2,640 people with Parkinson’s disease looking at the various comorbidities seen in these people